Lantheus Holdings, Inc. (LNTH)

Nasdaq · Common Stock · In Vitro & In Vivo Diagnostic Substances

One email a week from me: what it filed, which 13F holders added or cut, where its scores stand. Free.

Corporate structure

32 entities across 9 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.

Which other public companies file entities in the same places:

Delaware21 United Kingdom3 Ireland2 New Jersey1 Sweden1 Canada1 Switzerland1 Germany1 Nevada1

Subsidiaries of Lantheus Holdings, Inc. as disclosed in its SEC filing
Entity	Jurisdiction	Note
Commerce Street LLC	New Jersey
ACP Lantern Real Estate, LLC	Delaware
Aphelion LLC	Delaware
Cerveau Technologies, Inc.	Delaware
Evergreen Discovery, LLC	Delaware
Evergreen Theragnostics, Inc.	Delaware
Excelsior Life Sciences Ireland Limited	Ireland
EXINI Diagnostics AB	Sweden
Lantheus Alpha Therapy, LLC	Delaware
Lantheus EU Limited	Ireland
Lantheus Five, LLC	Delaware
Lantheus Medical Imaging, Inc.	Delaware
Lantheus MI Canada, Inc.	Canada
Lantheus MI Intermediate, Inc.	Delaware
Lantheus MI Real Estate, LLC	Delaware
Lantheus MI UK Limited	United Kingdom
Lantheus Omega, LLC	Delaware
Lantheus One, LLC	Delaware
Lantheus Radiopharmaceuticals UK Limited	United Kingdom
Lantheus Switzerland GmbH	Switzerland
Lantheus Three, LLC	Delaware
Lantheus Two, LLC	Delaware
Life Molecular Imaging GmbH	Germany
Life Molecular Imaging LLC	Delaware
Life Molecular Imaging Limited	United Kingdom
Meilleur Technologies, Inc.	Delaware
MNTX Royalties Sub LLC	Delaware
Molecular Insight Pharmaceuticals, Inc.	Delaware
Progenics Pharmaceuticals Nevada, Inc.	Nevada
Progenics Pharmaceuticals, Inc.	Delaware
PSMA Development Company LLC	Delaware
SPECT HoldCo LLC	Delaware

Financial health

Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

4 / 8

PASSReturn on assets positiveROA 10.5%
PASSOperating cash flow positiveOCF 390M
FAILReturn on assets improving15.8% → 10.5%
PASSCash flow exceeds earningsOCF 390M vs NI 234M
FAILLong-term debt ratio fallingno debt reported
FAILCurrent ratio improving5.52 → 2.70
PASSNo share dilution72M → 68M shares
FAILGross margin improving64.4% → 61.1%
FAILAsset turnover improving0.77× → 0.69×

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2020	$339.4M	−$13.5M	$3.9M	40.9%	54,134,000
FY2021	$425.2M	−$71.3M	$41.8M	44.1%	67,486,000
FY2022	$935.1M	$28.1M	$21.8M	62.2%	70,671,000
FY2023	$1.3B	$326.7M	$259.9M	54.7%	70,239,000
FY2024	$1.5B	$312.4M	—	64.4%	71,651,000
FY2025	$1.5B	$233.6M	—	61.1%	68,443,000

Ownership flow

1 institutions tracked — 1 added, 0 reduced.

Institutional holders of Lantheus Holdings, Inc. and their share-count change
Manager	Kind	Shares	Change	Value
GEODE CAPITAL MANAGEMENT, LLC	Index	1,841,367	+75,415	$204.3M

From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.

Identity

CIK: 0001521036
LEI: 5299005HUB5IOJGO7S39
FIGI: BBG006Q52RD0
SIC: 2835 · In Vitro & In Vivo Diagnostic Substances
Incorporated: DE
Headquarters: BEDFORD, MA

Ownership

Institutional: 116.8%
Institutions: 599
Insiders: 1.7%

Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.

Other in vitro & in vivo diagnostic substances companies

Lantheus Holdings, Inc. files under SIC 2835 — all 4 in vitro & in vivo diagnostic substances companies compared on assets and F-score.

QuidelOrtho CorpQDEL IDEXX LABORATORIES INC /DEIDXX NEOGEN CORPNEOG

Questions about Lantheus Holdings, Inc.

How many subsidiaries does Lantheus Holdings, Inc. file with the SEC?: 32, listed in its most recent exhibit 21. They are incorporated across 9 jurisdictions, led by New Jersey, Delaware, Ireland. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.
Is Lantheus Holdings, Inc. financially healthy?: Lantheus Holdings, Inc. scores 4 out of 8 on the Piotroski F-score. Only 8 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of Lantheus Holdings, Inc.?: Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are GEODE CAPITAL MANAGEMENT, LLC (adding). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

This page is one panel of the terminal

The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.

Download the terminal See pricing

Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.

Corporate structure

32 entities across 9 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.

Entity

Jurisdiction

Note

Commerce Street LLC

New Jersey

ACP Lantern Real Estate, LLC

Delaware

Aphelion LLC

Delaware

Cerveau Technologies, Inc.

Delaware

Evergreen Discovery, LLC

Delaware

Evergreen Theragnostics, Inc.

Delaware

Excelsior Life Sciences Ireland Limited

Ireland

EXINI Diagnostics AB

Sweden

Lantheus Alpha Therapy, LLC

Delaware

Lantheus EU Limited

Ireland

Lantheus Five, LLC

Delaware

Lantheus Medical Imaging, Inc.

Delaware

Lantheus MI Canada, Inc.

Canada

Lantheus MI Intermediate, Inc.

Delaware

Lantheus MI Real Estate, LLC

Delaware

Lantheus MI UK Limited

United Kingdom

Lantheus Omega, LLC

Delaware

Lantheus One, LLC

Delaware

Lantheus Radiopharmaceuticals UK Limited

United Kingdom

Lantheus Switzerland GmbH

Switzerland

Lantheus Three, LLC

Delaware

Lantheus Two, LLC

Delaware

Life Molecular Imaging GmbH

Germany

Life Molecular Imaging LLC

Delaware

Life Molecular Imaging Limited

United Kingdom

Meilleur Technologies, Inc.

Delaware

MNTX Royalties Sub LLC

Delaware

Molecular Insight Pharmaceuticals, Inc.

Delaware

Progenics Pharmaceuticals Nevada, Inc.

Nevada

Progenics Pharmaceuticals, Inc.

Delaware

PSMA Development Company LLC

Delaware

SPECT HoldCo LLC

Delaware

Financial health

Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

4 / 8

PASSReturn on assets positiveROA 10.5%
PASSOperating cash flow positiveOCF 390M
FAILReturn on assets improving15.8% → 10.5%
PASSCash flow exceeds earningsOCF 390M vs NI 234M
FAILLong-term debt ratio fallingno debt reported
FAILCurrent ratio improving5.52 → 2.70
PASSNo share dilution72M → 68M shares
FAILGross margin improving64.4% → 61.1%
FAILAsset turnover improving0.77× → 0.69×

Year

Revenue

Net income

Free cash flow

Gross margin

FY2020

$339.4M

−$13.5M

$3.9M

40.9%

54,134,000

FY2021

$425.2M

−$71.3M

$41.8M

44.1%

67,486,000

FY2022

$935.1M

$28.1M

$21.8M

62.2%

70,671,000

FY2023

$1.3B

$326.7M

$259.9M

54.7%

70,239,000

FY2024

$1.5B

$312.4M

—

64.4%

71,651,000

FY2025

$1.5B

$233.6M

—

61.1%

68,443,000

Ownership flow

1 institutions tracked — 1 added, 0 reduced.

Institutional holders of Lantheus Holdings, Inc. and their share-count change
Manager	Kind	Shares	Change	Value
GEODE CAPITAL MANAGEMENT, LLC	Index	1,841,367	+75,415	$204.3M

Questions about Lantheus Holdings, Inc.

How many subsidiaries does Lantheus Holdings, Inc. file with the SEC?

32, listed in its most recent exhibit 21. They are incorporated across 9 jurisdictions, led by New Jersey, Delaware, Ireland. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.

Is Lantheus Holdings, Inc. financially healthy?

Lantheus Holdings, Inc. scores 4 out of 8 on the Piotroski F-score. Only 8 of the nine tests could be computed from what it filed; the rest need a prior year it has not reported. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.

Who are the largest institutional holders of Lantheus Holdings, Inc.?

Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are GEODE CAPITAL MANAGEMENT, LLC (adding). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.